DP-1 Activators
DP-1 activators, also known as Dipeptidyl peptidase-1 activators, are a class of chemical compounds that play a crucial role in modulating specific biological processes within the human body. These compounds primarily target the enzyme dipeptidyl peptidase-1 (DP-1), which is a member of the serine protease family. DP-1 is a multifunctional enzyme found predominantly in lysosomes, cellular compartments responsible for breaking down various biomolecules. Its primary function is the cleavage of dipeptides from the N-terminus of various proteins, particularly those with proline or alanine residues. DP-1 activators are designed to enhance the enzymatic activity of DP-1, thereby influencing the proteolytic degradation of specific proteins in a controlled manner.
DP-1 activators are notable for their potential impact on cellular homeostasis and regulatory pathways. By increasing DP-1 activity, these compounds can modify the processing and degradation of key cellular proteins, influencing processes such as autophagy, antigen presentation, and the regulation of immune responses. This class of chemicals has attracted significant attention in the field of basic cellular research, as they provide a valuable tool for scientists seeking to dissect and understand the intricate mechanisms governing protein turnover and intracellular protein trafficking.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein can inhibit protein tyrosine kinases, potentially reducing the phosphorylation of pRb. This could lead to increased availability of DP-1 to bind to E2F and enhance its transcriptional activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor that can reduce the phosphorylation of pRb, increasing the availability of DP-1 to bind to E2F and enhancing its transcriptional activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can inhibit protein kinases, potentially reducing the phosphorylation of pRb. This could lead to increased availability of DP-1 to bind to E2F and enhance its transcriptional activity. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol is a CDK inhibitor that can reduce the phosphorylation of DP-1, thereby increasing the availability of DP-1 to bind to E2F and enhancing its transcriptional activity. | ||||||
N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine Methanesulfonate | 1231930-82-7 | sc-496536 | 2.5 mg | $398.00 | ||
LY2835219, also known as Abemaciclib, is a selective inhibitor of CDK4/6 and can prevent the phosphorylation of pRb, thereby facilitating the binding of DP-1 to E2F. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $247.00 $888.00 | 1 | |
Dinaciclib is a potent CDK inhibitor that can reduce the phosphorylation of DP-1, thereby increasing the availability of DP-1 to bind to E2F and enhancing its transcriptional activity. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Ribociclib is a selective inhibitor of CDK4/6 that can prevent the phosphorylation of pRb, thereby facilitating the binding of DP-1 to E2F. | ||||||